Scientists Map Entire Human Gut at Single Cell Resolution
From: UNC School of Medicine at Chapel
Hill
February 17, 2022 -- UNC School of Medicine scientists led by
Scott Magness, PhD, sequenced the genes expressed in individual single cells
from human digestive tracts to discover new cell-type characteristics and gain
insights into important cell functions such as nutrient absorption and immune
defense.
If you get nervous, you might feel
it in your gut. If you eat chili, your gut might revolt, but your friend can
eat anything and feel great. You can pop ibuprofen like candy with no ill
effects, but your friend’s belly might bleed and she might get no pain relief.
Why is this? The quick answer is because we’re all different. The next
questions are how different exactly, and what do these
differences mean for health and disease? Answering these is much more
difficult, but the UNC School of Medicine lab of Scott Magness, PhD, is
revealing some interesting scientific answers.
For the first time, the Magness lab used
entire human GI tracts from three organ donors to show how cell types differ
across all regions of the intestines, to shed light on cellular functions, and
to show gene expression differences between these cells and between
individuals.
This work, published in Cellular
and Molecular Gastroenterology and Hepatology, opens the door to
exploring the many facets of gut health in a much more precise manner at
greater resolution than ever before.
“Our lab showed it’s possible to learn
about each cell type’s function in important processes, such as nutrient
absorption, protection from parasites, and the production of mucus and hormones
that regulate eating behavior and gut motility,” said Magness, associate professor
in the Joint UNC-NC State Department of Biomedical Engineering and senior
author of the paper. “We also learned how the gut lining might interact with
the environment through receptors and sensors, and how drugs could interact
with different cell types.”
The Sensitive Gut
Think of a typical pharmaceutical
commercial voiceover when the voice actor pleasantly recites possible side
effects, such as diarrhea, vomiting, intestinal bleeding, and other unpleasant
collateral damage. Well, the Magness
lab is attempting to understand why those side effects happen, down to
the level of individual cells, their functions, their locations, and their
genes.
For this research, the Magness lab
focused on the epithelium: the single-cell thick layer separating the inside of
the intestines and colon from everything else. Like other cell populations and
the microbiota, the epithelium is incredibly important to human health, and for
years scientists have been exploring it. But until now, researchers could only
take tiny biopsies the size of grains of rice from a few parts of the digestive
tract, usually from the colon or limited regions of the small intestine.
“Such exploration would be like looking
at the United States from space but only investigating what’s going on in
Massachusetts, Oklahoma, and California,” Magness said. “To really learn
about the country, we’d want to see everything.”
Magness leaned on co-first authors,
postdoctoral fellow Joseph Burclaff, PhD, and graduate student, Jarrett Bliton,
both trainees in the Magness lab.
“Not only do we want to identify where
the cells are located, but we want to know exactly which cell types do what,
and why,” Burclaff said. “So, staying with the map analogy, we don’t want to
just say, ‘oh, there’s North Carolina’. We want to know where to get the best
barbecue. We want a ground level view to know as much as possible.”
In the past, researchers would mash up
those rice-sized biopsies to identify all epithelial cell types and learn some
general features of these cells. Magness’s approach was to sample thousands of
individual cells from every part of the lower digestive tract (small intestine
and colon) to create an atlas and then study the potential roles of these cells
through the genes that each cell expresses. Knowing all of this would deepen
scientific knowledge about the gut epithelium and hopefully encourage other
scientists to explore each cell’s function in biology, in disease, and in the
unfortunate scenario of pharmaceutical side effects.
To do such a deep individual cell dive,
Magness needed two things: better technology and the entire digestive tracts of
humans.
The Biology of Data
UNC-Chapel Hill acquired
state-of-the-art RNA sequencing technology several years ago for the creation
of the Advanced Analytics Core Facility through the UNC Center for
Gastrointestinal Disease and Biology, which developed the scientific and
intellectual heft – research faculty, staff, postdocs, and students – to use
state-of-the-art equipment.
The Magness Group acquired human
digestive tracts through a research agreement with organ donor services at
HonorBridge. When intestines are harvested for transplant and if they are not
claimed by higher-priority groups, HonorBridge staff coordinates with the
Magness Group to donate the transplant-grade organs for research.
Six to eight hours after harvest, the
Magness lab receives intact intestinal tracts, each about 15 to 30 feet long.
They remove the epithelial layer, which is one long connected piece of tissue
despite being only one cell thick. Then the researchers use enzymes to break
down the epithelium into individual cells. For this study, they repeated this
for organs from three separate donors.
Using sequencing technology to
characterize gene expression, the Magness group first extracts RNA from each
cell while keeping each cell separate, and then they run single-cell
sequencing, which takes a snapshot of which genes each intestinal cell is expressing
and how much.
“The picture we get from each cell is a
mosaic of all the different types of genes the cells make and this complement
of genes creates a ‘signature’ to tell us what kind of cell it is and
potentially what it is doing,” Magness said. “Is it a stem cell or a mucous
cell or a hormone-producing cell or an immune-signaling cell?
Burclaff added, “We were able to see the
differences in cell types throughout the entire digestive tracts, and we can
see different gene expression levels in the same cell types from three
different people. We can see the different sets of genes turned on or off in
individual cells. This is how, for instance, we might begin to understand why
some people form toxicity to certain foods or drugs and some people don’t.”
A major problem with this kind of
research is the sheer amount of data produced. The single cell sequencing picks
up about 11,000 ‘reads’, or individual samples of gene products in just one
cell, and in many thousands of individual cells, each with different combinations
of the 20,000-plus human genes that are turned on or off. This creates almost
140,000,000 data points for all the 12,590 cells in the study that have to be
put into a “visual” format so that scientists can make sense of the vast amount
of information.
“The human brain can only comprehend two
dimensions, three is challenging,” Magness said. “Add time, and it’s even
trickier to comprehend what a single cell is up to. The amount of data our
experiments produced was basically millions of dimensions all at once.”
Bliton devised computational techniques
to filter the data to produce a manageable data set that included cell
populations from all portions of the GI tract. Then, based on what Magness and
other researchers had already learned of each cell type, Bliton could
computationally identify each cell type from each region. He then plotted these
data in a manner that humans can understand and interpret.
Reining in the immense data allowed the
scientists to learn a lot about each cell type. Consider the tuft cell,
discovered 40 years ago and so named because they look as if they have tufts of
hair on their surface. Turns out these tuft cells express similar genes as
those on taste buds on the tongue. Other researchers discovered that these tuft
cells sensed worm infections and sent signals to the immune system to begin
waging war. The Magness lab showed that tuft cells exhibit a set of genes
thought to be important for sensing and “tasting” other kinds of intestinal
content so it can signal the immune system if need be. This would represent a
much broader function than sensing if there’s a parasite in your gut or not.
“Not only did we describe every single
cell type and every single gene they express individually, but we also looked
at potential functions,” Burclaff said. “If you look at intestinal mucus, which
is a complex mixture that protects the cells, we show which cells express
various mucin proteins, how much, and in which regions of the digestive tract.
We looked at where specific enzymes that digest food are expressed. We looked
at cells with anti-inflammatory gene expression and synapse genes where the gut
is probably connected to nerves so it can talk to the rest of the body. We
looked at aquaporins, proteins involved in transferring water through the
intestinal membrane.”
What the Magness group found was a whole
new level of variation in potential functions that had not previously been
appreciated through mashing up biopsy samples.
The researchers explored all epithelial
receptors – the cell surface proteins used to communicate with other cells and
molecules and with the environment of the gut. Magness and colleagues could see
which receptors were expressed the most and in which cell types, painting a new
picture of how cells might interact with gut contents such as nutrients,
microbes, toxins, and drugs.
“As far as we know, we’re the first to
do this kind of analysis across the length of the human gut from three full
donors,” Bliton said. “We can look at each cell type and predict which
pharmaceuticals might affect which cell type individually.”
For instance, there’s a class of drugs
to treat inflammatory bowel disease; they’re designed to hit specific targets,
certain immune cells that trigger inflammation. But the Magness lab learned
that some epithelial cells express the same genes as those in the immune cells
that are intended to be the target. This finding indicates there could be
“off-target” effects in epithelial cells that are not intended and could lead
to side-effects.
“This was not known,” Burclaff said.
“Lots of drugs have bad GI side effects. And it could be because the drugs are
affecting individual cells along the entire length of the GI tract. We show
where these receptors are most expressed and in which cell types.”
This kind of knowledge is just one
outcome from the Magness lab’s initial study.
“We want the scientific, medical, and
pharmaceutical community to use what we’ve found,” Magness said. “We adopted an
analytic approach to methodically address each cell type, produce easy-to-read
and accessible spreadsheets for most scientists, and show several examples of
what we can be discovered with this kind of high resolution, precision
approach.”
Funding for
this research came from the National Institutes of Health, the Katherine E.
Bullard Charitable Trust, the Crohn’s and Colitis Foundation, and the
University Cancer Research Fund at UNC-Chapel Hill.
Aside from
the aforementioned researchers, other authors are Keith Breau, Meryem Ok,
Ismael Gomez-Martinez, Jolene Ranek, Aadra Bhatt, Jeremy Purvis, and John
Woosley, all at UNC-Chapel Hill.
https://news.unchealthcare.org/2022/02/scientists-map-entire-human-gut-at-single-cell-resolution/
No comments:
Post a Comment